Figure 8

Screening of 1134 FDA-approved drugs in Kitra-SRS cells. Ten micromolar of 1134 FDA-approved drugs in our library were added to Kitra-SRS cells for 48 h. (a) Ten anticancer drugs that inhibited more than 80% cell viability in Kitra-SRS cells. (b) The antiproliferative efficacy of the drugs used in the donor patient.